TACR1 and colitis: SP could ameliorate colitis and intestinal epithelium disruption in DSS-induced mice, and the in vitro inflammation model of tumor necrosis factor-alpha (TNF-α)-stimulated human colon carcinoma cell line (Caco-2), which was dependent on its specific receptor NK1R.